IllustrativeIDEXX Laboratories Stock: $876 Target Backed by Cancer Dx Adoption Across 7,500 Practices
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
A stock target of $876 has been set for idexx laboratories, reportedly due to the adoption of cancer diagnostics across a large number of practices. The adoption is said to have occurred across 7,500 practices. This development is seen as backing the set stock target.